Stay updated on VIP152 for Relapsed CLL or Richter Syndrome Clinical Trial

Sign up to get notified when there's something new on the VIP152 for Relapsed CLL or Richter Syndrome Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the VIP152 for Relapsed CLL or Richter Syndrome Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    7 days ago
    Change Detected
    Summary
    The page’s display version (Revision) was updated from v3.5.2 to v3.5.3, indicating a site/browser UI update rather than a change to the clinical study information.
    Difference
    0.1%
    Check dated 2026-04-23T21:57:57.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    Revision indicator updated to v3.5.2 and removed v3.5.0.
    Difference
    0.1%
    Check dated 2026-04-16T12:36:08.000Z thumbnail image
  4. Check
    22 days ago
    No Change Detected
  5. Check
    29 days ago
    Change Detected
    Summary
    Added B-cell chronic lymphocytic leukemia as a condition term on the study page.
    Difference
    0.1%
    Check dated 2026-04-02T06:15:43.000Z thumbnail image
  6. Check
    43 days ago
    Change Detected
    Summary
    Added Revision: v3.5.0 and removed Revision: v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-18T20:57:57.000Z thumbnail image
  7. Check
    50 days ago
    Change Detected
    Summary
    Footer revision label updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-11T20:00:22.000Z thumbnail image
  8. Check
    79 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added, and the preceding funding-status notice as well as Revision: v3.4.1 were removed. These appear to be site-wide maintenance updates and do not alter the study details.
    Difference
    0.4%
    Check dated 2026-02-11T02:20:51.000Z thumbnail image

Stay in the know with updates to VIP152 for Relapsed CLL or Richter Syndrome Clinical Trial

Enter your email address, and we'll notify you when there's something new on the VIP152 for Relapsed CLL or Richter Syndrome Clinical Trial page.